Japan’s revised second-quarter GDP data expected


Stocks in Asia Pacific were set to open higher on Tuesday as investors await the release of Japan’s revised second-quarter gross domestic product data.

Futures pointed to a higher open for Japanese stocks, with the Nikkei futures contract in Chicago at 23,225 while its counterpart in Osaka was at 23,220. That compared against the Nikkei 225’s last close at 23,089.95.

Shares in Australia were also poised to see a positive start to their trading day. The SPI futures contract was at 5,949.0, as compared to the S&P/ASX 200’s last close at 5,944.80.

On the economic data front, Japan’s revised GDP figures for the second quarter are set to be out at around 7:50 a.m. HK/SIN. Preliminary estimates released in mid-August had shown the country’s GDP shrinking 27.8% on an annualized basis in April-June.

Investors will likely continue to monitor geopolitical developments.

China’s Foreign Ministry on Monday accused Washington of “blatant hegemony” after the U.S. Department of Defense said recently it was considering adding Semiconductor Manufacturing International Corporation to the Commerce Department’s so-called entity list. Meanwhile, tensions are also escalating between the U.K. and European Union, putting at risk chances of a post-Brexit trade deal in the coming months.

The U.S. dollar index, which tracks the greenback against a basket of its peers, was last at 92.719 after earlier seeing levels above 93.0.

The Japanese yen traded at 106.29 per dollar after seeing levels below 106.2 yesterday against the greenback. The Australian dollar changed hands at $0.7281 after seeing a momentary fall below $0.726 late last week.

Here’s a look at what’s on tap:

  • Japan: Second-quarter gross domestic product figures at 7:50 a.m. HK/SIN



Source link

Discover

Sponsor

Latest

Lawyer met with Trump to discuss criminal case

The defense lawyer for Michael Flynn told a judge on Tuesday that she had talked about Flynn's criminal case in a meeting with...

Pfizer’s Covid vaccine approved by FDA for emergency use

The Food and Drug Administration has approved Pfizer and BioNTech's coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic...

Privacy Concerns Hindering Digital Contact Tracing

Jennifer D. Oliva, JD, associate professor of law, Seton Hall University...

Mnuchin decision cuts Fed lending power, but sources say emergency programs can be revived

U.S. Treasury Secretary Steven Mnuchin and Federal Reserve Chair Jerome Powell share an elbow bump greeting prior to testifying before a House Financial...